Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather to chart the course for 2025 and take stock of the landscape, both financial and political.
Special report 2024: Meet 20 women breaking new ground in …
Oct 7, 2024 · Dedicated to the memory of Natalie Grover, who co-created the Women in Biopharma R&D special report while she was a reporter at Endpoints from 2018-2020. Natalie passed away earlier ...
News – Endpoints News
reset password. We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours. email
Endpoints 11
Sep 26, 2024 · We’re back with this year’s selection of the top eleven most promising biotechs. They’re taking big swings with cutting-edge science and proven leadership, and the industry is watching to see if they succeed — or fail. Either way, they’ll be bellwethers for where biotech is heading. Join a select group of industry leaders for this year’s awards gala in …
Agenda: Endpoints at #JPM24
Catalent CEO Alessandro Maselli will be back at the big JPM healthcare confab to talk with Endpoints News founder John Carroll about their top predictions of what’s coming up for the biotech industry in 2024.
Women in Biopharma 2023
Award Presentation . Though women account for roughly half of all employees in the biopharma industry — and growing, according to a recent BIO report — they occupy few executive and C-suite roles, especially in R&D.
Endpoints at #ESMO24
Sep 17, 2024 · ESMO is the oncology conference to watch this year — the Endpoints team is on the ground reporting on the latest readouts and pipeline updates from the European cancer drug scene. What pathways and targets show promise? Will practice-changing data readouts upend the competitive landscape? We’re making sense of the trove of data dropped with our experts.
Endpoints Careers - Find your next biopharma job
New benefit for Enterprise subscribers. All companies with an Enterprise subscription to Endpoints News will now receive two spotlight job postings per year at no charge.Contact your company subscriptions manager or DeAna ([email protected]) for more information.. For sales inquires or package requests, connect with Meg at [email protected].
The power of antigen-specific TCR signatures in developing next …
Discover the diverse applications of T-cell receptor (TCR) sequencing to identify antigen-specific T-cell responses and accelerate the development of next-generation cancer immunotherapies. This webinar highlights TCR signatures linked to cancer biomarkers and their potential applications in clinical trials. These findings provide clinically actionable insights into the adaptive immune response to